Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Keane

Showing results (411-420 of 438) with videos related to

Pageof 44
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 14, 2015
CXCL9 Regulates TGF-β1-Induced Epithelial to Mesenchymal Transition in Human Alveolar Epithelial CellsSarah L O'Beirne, Sinead M Walsh, Aurélie Fabre, et al.
Transplantation and Cellular Therapy|January 30, 2026
Caring for the HSCT Population: Clinician Perspectives on Challenges and Opportunities in Psychosocial Care DeliveryEmma P Keane, Fabian N Adri, Isabella S Larizza, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II. In vivo pharmacological characterizationE Bignon, R Alonso, M Arnone, et al.
Neuroscience|August 12, 2008
Effects of the beta3-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: relevance to its antidepressant/anxiolytic-like profileY Claustre, M Leonetti, V Santucci, et al.
European Radiology Experimental|November 3, 2020
Differentiating combined pulmonary fibrosis and emphysema from pure emphysema: utility of late gadolinium-enhanced MRIHannah Fleming, Simon M Clifford, Aoife Haughey, et al.
Psycho-Oncology|February 15, 2024
Gratitude, optimism, and satisfaction with life and patient-reported outcomes in patients undergoing hematopoietic stem cell transplantationHermioni L Amonoo, Elizabeth Daskalakis, Emma C Deary, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 3, 2008
Altered levels of CC chemokines during pulmonary CMV predict BOS and mortality post-lung transplantationS S Weigt, R M Elashoff, M P Keane, et al.
Transplantation and Cellular Therapy|April 5, 2025
A Structured Peer Support Intervention for Patients With Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation: Peer Support Interventionists' PerspectivesMichelle Guo, Emma P Keane, Michael Baliousis, et al.
Respirology (Carlton, Vic.)|August 29, 2023
Analysis of tissue lipidomics and computed tomography pulmonary fat attenuation volume (CT<sub>PFAV</sub> ) in idiopathic pulmonary fibrosisMarissa O'Callaghan, John Duignan, Elizabeth J Tarling, et al.
Transplantation and Cellular Therapy|October 6, 2024
A Biobehavioral Perspective on Caring for Allogeneic Hematopoietic Stem Cell Transplant Survivors with Graft-Versus-Host DiseaseSheila Lahijani, Maria Rueda-Lara, Natalie McAndrew, et al.
Pageof 44

Showing results (411-420 of 438) with videos related to

Sort By:
Pageof 44
Journal of Immunology (Baltimore, Md. : 1950)|August 14, 2015
CXCL9 Regulates TGF-β1-Induced Epithelial to Mesenchymal Transition in Human Alveolar Epithelial CellsSarah L O'Beirne, Sinead M Walsh, Aurélie Fabre, et al.
Transplantation and Cellular Therapy|January 30, 2026
Caring for the HSCT Population: Clinician Perspectives on Challenges and Opportunities in Psychosocial Care DeliveryEmma P Keane, Fabian N Adri, Isabella S Larizza, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II. In vivo pharmacological characterizationE Bignon, R Alonso, M Arnone, et al.
Neuroscience|August 12, 2008
Effects of the beta3-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: relevance to its antidepressant/anxiolytic-like profileY Claustre, M Leonetti, V Santucci, et al.
European Radiology Experimental|November 3, 2020
Differentiating combined pulmonary fibrosis and emphysema from pure emphysema: utility of late gadolinium-enhanced MRIHannah Fleming, Simon M Clifford, Aoife Haughey, et al.
Psycho-Oncology|February 15, 2024
Gratitude, optimism, and satisfaction with life and patient-reported outcomes in patients undergoing hematopoietic stem cell transplantationHermioni L Amonoo, Elizabeth Daskalakis, Emma C Deary, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 3, 2008
Altered levels of CC chemokines during pulmonary CMV predict BOS and mortality post-lung transplantationS S Weigt, R M Elashoff, M P Keane, et al.
Transplantation and Cellular Therapy|April 5, 2025
A Structured Peer Support Intervention for Patients With Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation: Peer Support Interventionists' PerspectivesMichelle Guo, Emma P Keane, Michael Baliousis, et al.
Respirology (Carlton, Vic.)|August 29, 2023
Analysis of tissue lipidomics and computed tomography pulmonary fat attenuation volume (CT<sub>PFAV</sub> ) in idiopathic pulmonary fibrosisMarissa O'Callaghan, John Duignan, Elizabeth J Tarling, et al.
Transplantation and Cellular Therapy|October 6, 2024
A Biobehavioral Perspective on Caring for Allogeneic Hematopoietic Stem Cell Transplant Survivors with Graft-Versus-Host DiseaseSheila Lahijani, Maria Rueda-Lara, Natalie McAndrew, et al.
Pageof 44